Canadian Medical Association Journal eCMAJ Home  

Drug advisories

CMAJ is committed to publishing advisories of serious adverse drug reactions from Health Canada and the US Food and Drug Administration (FDA) as soon as they are available.

For more information about drug reactions reported in Canada, see also the Canadian Adverse Drug Reaction Newsletter.

For safety alerts, public health advisories, press releases and other notices, see Advisories to Health Professionals on the Health Canada site.

Most recent advisories

Advisories by drug name

 

Copyright 2001 Canadian Medical Association or its licensors